Clearbridge subsidiary to issue $2 mil in convertible bonds

Clearbridge subsidiary to issue $2 mil in convertible bonds

By: 
Michelle Zhu
25/03/19, 06:34 pm

SINGAPORE (Mar 25): Clearbridge Health Limited’s subsidiary, Clearbridge Biophotonics, is set to issue $2 million in convertible bonds to develop its proprietary computational imaging microscopy technology with the aim of commercialisation.  

Enterprise Singapore’s investment arm SEEDS Capital will subscribe for $1 million of the convertible bonds.

At the same time, Clearbridge’s wholly owned subsidiary Clearbridge BSA will convert existing loans to Clearbridge Biophotonics for another $1 million of the convertible bonds.

In its filing on Monday, the group highlights Clearbridge Biophotonics’ potential for growth through its algorithm-powered microscopy technology, which targets the live cell imaging market that is estimated to reach US$2.9 billion by 2023, according to a MarketsandMarkets report.

In particular, the group says Clearbridge Biophotonics’ unique imaging devices are positioned to disrupt the live cell imaging market by addressing “unmet needs in live cell imaging for drug discovery and biomedical research” as they offer the ability to perform high throughput, concurrent imaging of multiple cell responses.

As such, they offer pharmaceutical companies and researchers several new value propositions, including novel insights in drug discovery and development, as well as cost- and time-saving solutions.

“This niche market [live cell imaging] is growing rapidly with the rising incidence of cancer and accelerated drug development efforts to combat cancer. There are huge market opportunities in this specialised area and Clearbridge Biophotonics’ unique microscopy technology is attracting investor interest from US venture capital firms specializing in life sciences investments,” says Jeremy Yee, executive director and CEO of Clearbridge.

Shares in the group closed 1.35% lower at 15 cents on Monday.

Right timing: STI’s upclimb supported by momentum and moving averages

SINGAPORE (Apr 20): There has been little change in the trend and chart pattern of the Straits Times Index. The index has been on a very glacial ascent towards 3,420, the target indicated when the index broke out of resistance at 3,190 in mid-Jan. Quarterly momentum eased during the past four trading sessions. The 100- and 200-day moving averages have turned positive. This coupled with positively placed DIs and rising ADX should continue to underpin the STI. The only cautionary signals are the somewhat overbought levels of short term stochastics and 21-day RSI, and stagnant vol....
Read More >>

SMI takes legal action against Hyflux; Maybank moves on Tuaspring

(Apr 20): SM Investments (SMI) has terminated its rescue agreement with Hyflux, it announced on Friday. Hyflux, on its part, had already on April 4 terminated the same agreement with SMI. SMI claims it has thus far abided by the agreement. “To clarify, SMI does not accept the purported termination of the Restructuring Agreement by Hyflux on 4 April 2019. This is because the termination was not in accordance with the terms of the Restructuring Agreement," said SMI. Under the agreement reached last October, SMI, led by Indonesian tycoon Anthoni Salim, was to have invested $530 million in....
Read More >>

CCT reports 3.8% higher 1Q DPU of 2.20 cents on higher property contributions

SINGAPORE (April 19): The manager of CapitaLand Commercial Trust (CCT) has reported a 1Q19 distribution per unit (DPU) of 2.20 cents, rising 3.8% y-o-y from 2.12 cents due to higher contributions from Gallileo and Asia Square Tower 2. Gross revenue and net property income (NPI) for the quarter increased by 3.5% and 3.4% to $99.8 million and $79.8 million, respectively. This comes after booking contributions from Gallileo – an office building in Frankfurt, Germany which the trust acquired a 94.9% stake in during June 2018 – as well as higher occupancy at Asia Square Tower 2, both of w....
Read More >>